Genomi Diagnostic announcement, shareholders Hengqin Junlian and LOYAL CLASS collectively hold 6.01% of the company's shares, planning to reduce their holdings by no more than 7,219,940 shares through centralized bidding and block trading methods, accounting for 1.80% of the total share capital. The reduction period is from October 25, 2024 to January 24, 2025, and the reduction price is determined by the market price. This shareholding reduction is due to its own capital needs and will not affect the company's governance structure and ongoing operations.
科美诊断：股东拟减持不超1.80%股份
Corme Diagnostics: Shareholders plan to reduce their shareholding by no more than 1.80%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated